CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-02 | Dubin Glenn Director | Grant or award | +6,470 | $1.70 | $11K | 19,030 |
| 2023-10-02 | GROGAN DONNA ROY Director | Grant or award | +8,089 | $1.70 | $14K | 19,827 |
| 2023-09-18 | Hirsch Andrew President & CEO | Grant or award · Stock Option (Right to Buy) | +489,600 | 489,600 | ||
| 2023-09-18 | Schick Kelly Chief People Officer | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2023-09-18 | Fisher Stewart Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2023-09-18 | Boyle Scott N Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2023-09-18 | Siegel Jolie Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2023-09-18 | Adams Kendra Chief Financial Officer | Grant or award | +25,000 | 46,640 | ||
| 2023-09-18 | Adams Kendra Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +111,000 | 111,000 | ||
| 2023-08-30 | Hirsch Andrew President & CEO | Option exercise | +7,500 | 116,106 | ||
| 2023-08-30 | Hirsch Andrew President & CEO | Shares withheld for taxes | −2,205 | $2.93 | $6K | 113,901 |
| 2023-08-30 | Hirsch Andrew President & CEO | Option exercise · Performance Restricted Stock Units | −7,500 | 55,000 | ||
| 2023-08-30 | Siegel Jolie Chief Legal Officer | Option exercise | +2,250 | 27,347 | ||
| 2023-08-30 | Siegel Jolie Chief Legal Officer | Shares withheld for taxes | −661 | $2.93 | $2K | 26,686 |
| 2023-08-30 | Siegel Jolie Chief Legal Officer | Option exercise · Performance Restricted Stock Units | −2,250 | 16,500 | ||
| 2023-08-30 | White Lauren Chief Financial Officer | Option exercise | +2,250 | 33,347 | ||
| 2023-08-30 | White Lauren Chief Financial Officer | Shares withheld for taxes | −661 | $2.93 | $2K | 32,686 |
| 2023-08-30 | White Lauren Chief Financial Officer | Option exercise · Performance Restricted Stock Units | −2,250 | 16,500 | ||
| 2023-08-30 | Schick Kelly Chief People Officer | Option exercise | +2,250 | 27,347 | ||
| 2023-08-30 | Schick Kelly Chief People Officer | Shares withheld for taxes | −661 | $2.93 | $2K | 26,686 |
Page 11 of 27 · 525 trades